Developing an effective malaria vaccine is challenging due to the complex life cycle of the Plasmodium parasite, which involves both human and mosquito hosts. Humans act as intermediate hosts where the parasite undergoes asexual reproduction, while mosquitoes are the definitive hosts where sexual reproduction occurs. This intricate cycle, coupled with the parasite's ability to evade the human immune system and its antigenic variation, makes it difficult to target effectively with a vaccine.